GenWay Biotech extends the You Test You program overseas

GenWay Biotech, Inc., the US-based diagnostic company that recently launched the You Test YouTM Cancer Assessment is expanding this cancer testing program internationally. An agreement has been executed to offer the You Test YouTM Cancer Assessment in Greece starting in April. Additional agreements are in progress for other European nations as well. GenWay currently offers this test in the United States and Canada.

Dr. Sergey Sikora, Vice President of Business Development, said, "The agreement with Greece is one of many on the horizon which will make the You Test You cancer testing service readily available to many countries worldwide that are interested in revolutionizing healthcare and facilitating self-testing for cancer."

The You Test YouTM Cancer Assessment is a unique program that enables consumers to directly access a cancer testing service without having to make an appointment with their own doctor. The You Test You platform is designed to empower consumers to be proactive about their health and their risk of having cancer. The test measures biomarkers associated with numerous types of cancer and aids in the early detection of cancer.

Early detection of cancer is the key to fighting cancer successfully. Extending this program to other countries could bring them to a higher level of healthcare with individuals being able to self-monitor themselves for diseases such as cancer.

Provided by GenWay Biotech